Anthracycline Chemotherapy-Induced Cardiotoxicity in Breast Cancer Survivors: A Systematic Review

被引：8
作者：
Lin, Katherine Jinghua [1 ]
Lengacher, Cecile A. [2 ]
机构：
[1] Pasco Hernando State Coll, Wesley Chapel, FL 33543 USA
[2] Univ S Florida, Coll Nursing, Tampa, FL USA
来源：
ONCOLOGY NURSING FORUM | 2019年 / 46卷 / 05期
关键词：
anthracycline; cardiotoxicity; breast cancer; survivors; HEART-FAILURE; ADJUVANT CHEMOTHERAPY; CARDIAC DYSFUNCTION; SYSTOLIC FUNCTION; FOLLOW-UP; TRASTUZUMAB; DOXORUBICIN; EPIRUBICIN; RISK; ECHOCARDIOGRAPHY;
D O I：
10.1188/19.ONF.E145-E158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PROBLEM IDENTIFICATION: This review identifies specific cardiotoxicity related to anthracycline chemotherapy, specific risk factors related to increased anthracycline chemotherapy-induced cardiotoxicity, and underlying mechanisms of action of anthracycline chemotherapy-induced cardiotoxicity. LITERATURE SEARCH: PubMed (R) CINAHL (R) Embase (R), and Web of Science were searched in May 2018 using keywords related to heart diseases, anthracycline chemotherapy, and breast cancer. DATA EVALUATION: Data were extracted, and study quality was assessed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. SYNTHESIS: 1.117 articles were identified through the literature search. After a review of the abstracts and articles, 15 clinical studies were identified for the final analysis by using exclusion and inclusion criteria. IMPLICATIONS FOR PRACTICE: Nurses should recognize the critical elements for prevention and early detection of anthracycline chemotherapy-induced cardiotoxicity.
引用
收藏
页码：E145 / E158
页数：14
相关论文
共 54 条
  • [1] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    Albain, K.
    Anderson, S.
    Arriagada, R.
    Barlow, W.
    Bergh, J.
    Bliss, J.
    Buyse, M.
    Cameron, D.
    Carrasco, E.
    Clarke, M.
    Correa, C.
    Coates, A.
    Collins, R.
    Costantino, J.
    Cutter, D.
    Cuzick, J.
    Darby, S.
    Davidson, N.
    Davies, C.
    Davies, K.
    Delmestri, A.
    Di Leo, A.
    Dowsett, M.
    Elphinstone, P.
    Evans, V.
    Ewertz, M.
    Gelber, R.
    Gettins, L.
    Geyer, C.
    Goldhirsch, A.
    Godwin, J.
    Gray, R.
    Gregory, C.
    Hayes, D.
    Hill, C.
    Ingle, J.
    Jakesz, R.
    James, S.
    Kaufmann, M.
    Kerr, A.
    MacKinnon, E.
    McGale, P.
    McHugh, T.
    Norton, L.
    Ohashi, Y.
    Paik, S.
    Pan, H. C.
    Perez, E.
    Peto, R.
    Piccart, M.
    [J]. LANCET, 2012, 379 (9814) : 432 - 444
  • [2] Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
    Albain, Kathy S.
    Barlow, William E.
    Ravdin, Peter M.
    Farrar, William B.
    Burton, Gary V.
    Ketchel, Steven J.
    Cobau, Charles D.
    Levine, Ellis G.
    Ingle, James N.
    Pritchard, Kathleen I.
    Lichter, Allen S.
    Schneider, Daniel J.
    Abeloff, Martin D.
    Henderson, I. Craig
    Muss, Hyman B.
    Green, Stephanie J.
    Lew, Danika
    Livingston, Robert B.
    Martino, Silvana
    Osborne, C. Kent
    [J]. LANCET, 2009, 374 (9707) : 2055 - 2063
  • [3] Anthracycline-induced chronic cardiotoxicity and heart failure
    Appel, Jon M.
    Nielsen, Dorte
    Zerahn, Bo
    Jensen, Benny V.
    Skagen, Knud
    [J]. ACTA ONCOLOGICA, 2007, 46 (05) : 576 - 580
  • [4] Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer
    Appel, Jon M.
    Jensen, Benny V.
    Nielsen, Dorte L.
    Ryberg, Marianne
    Zerahn, Bo
    [J]. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2010, 26 (02) : 217 - 223
  • [5] Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
    Bowles, Erin J. Aiello
    Wellman, Robert
    Feigelson, Heather Spencer
    Onitilo, Adedayo A.
    Freedman, Andrew N.
    Delate, Thomas
    Allen, Larry A.
    Nekhlyudov, Larissa
    Goddard, Katrina A. B.
    Davis, Robert L.
    Habel, Laurel A.
    Yood, Marianne Ulcickas
    McCarty, Catherine
    Magid, David J.
    Wagner, Edward H.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (17): : 1293 - 1305
  • [6] Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study
    Boyd, Anita
    Stoodley, Paul
    Richards, David
    Hui, Rina
    Harnett, Paul
    Vo, Kim
    Marwick, Tom
    Thomas, Liza
    [J]. PLOS ONE, 2017, 12 (04):
  • [7] Cardiotoxicity Debated for Anthracyclines and Trastuzumab in Breast Cancer
    Brower, Vicki
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (12): : 835 - 836
  • [8] Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
    Cardinale, Daniela
    Colombo, Alessandro
    Bacchiani, Giulia
    Tedeschi, Ines
    Meroni, Carlo A.
    Veglia, Fabrizio
    Civelli, Maurizio
    Lamantia, Giuseppina
    Colombo, Nicola
    Curigliano, Giuseppe
    Fiorentini, Cesare
    Cipolla, Carlo M.
    [J]. CIRCULATION, 2015, 131 (22) : 1981 - 1988
  • [9] Contraction Timing Patterns in Patients Treated for Breast Cancer Before and After Anthracyclines Therapy
    Cheng, Kai-Hung
    Handschumacher, Mark D.
    Borges Leal Assuncao, Bruna Morhy
    Sebag, Igal A.
    Halpern, Elkan F.
    Scherrer-Crosbie, Marielle
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2017, 30 (05) : 454 - 460
  • [10] Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice
    Deng, Shiwei
    Kruger, Anke
    Schmidt, Albrecht
    Metzger, Annegret
    Yan, Tiandong
    Goedtel-Armbrust, Ute
    Hasenfuss, Gerd
    Brunner, Friedrich
    Wojnowski, Leszek
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 380 (01) : 25 - 34
123456